These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25933818)

  • 1. Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?
    Saad A; Herrmann SM; Textor SC
    Physiology (Bethesda); 2015 May; 30(3):175-82. PubMed ID: 25933818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal artery stenosis: medical versus interventional therapy.
    Textor SC; Lerman LO
    Curr Cardiol Rep; 2013 Oct; 15(10):409. PubMed ID: 23990274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells and chronic renal artery stenosis.
    Oliveira-Sales EB; Boim MA
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F6-9. PubMed ID: 26538439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?
    Textor SC; Lerman LO
    J Am Soc Nephrol; 2015 Sep; 26(9):2074-80. PubMed ID: 25868641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease.
    Saad A; Dietz AB; Herrmann SMS; Hickson LJ; Glockner JF; McKusick MA; Misra S; Bjarnason H; Armstrong AS; Gastineau DA; Lerman LO; Textor SC
    J Am Soc Nephrol; 2017 Sep; 28(9):2777-2785. PubMed ID: 28461553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Hypoxia in Ischemic Chronic Kidney Disease.
    Textor SC; Lerman LO
    Semin Nephrol; 2019 Nov; 39(6):589-598. PubMed ID: 31836041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy.
    Chen XJ; Zhang X; Jiang K; Krier JD; Zhu X; Conley S; Lerman A; Lerman LO
    J Cell Physiol; 2020 Dec; 235(12):9806-9818. PubMed ID: 32430932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal artery stenosis: if and when to intervene.
    Textor SC; McKusick MM
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):144-51. PubMed ID: 26741885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of renal revascularization in ischemic nephropathy.
    Weaver FA; Modrall JG
    Surg Annu; 1994; 26():135-50. PubMed ID: 8303518
    [No Abstract]   [Full Text] [Related]  

  • 10. Issues in renovascular disease and ischemic nephropathy: beyond ASTRAL.
    Textor SC
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):139-45. PubMed ID: 21157335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis.
    Eirin A; Li Z; Zhang X; Krier JD; Woollard JR; Zhu XY; Tang H; Herrmann SM; Lerman A; Textor SC; Lerman LO
    Hypertension; 2012 Nov; 60(5):1242-9. PubMed ID: 23045468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
    Tögel F; Weiss K; Yang Y; Hu Z; Zhang P; Westenfelder C
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renovascular hypertension and ischemic nephropathy.
    Textor SC; Lerman L
    Am J Hypertens; 2010 Nov; 23(11):1159-69. PubMed ID: 20864945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous revascularization for ischemic nephropathy: the past, present, and future.
    Textor SC; Misra S; Oderich GS
    Kidney Int; 2013 Jan; 83(1):28-40. PubMed ID: 23151953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From anatomy to function: diagnosis of atherosclerotic renal artery stenosis.
    Odudu A; Vassallo D; Kalra PA
    Expert Rev Cardiovasc Ther; 2015 Dec; 13(12):1357-75. PubMed ID: 26480218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic process, renovascular disease and outcomes from bench to bedside.
    Lerman LO; Chade AR
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):583-7. PubMed ID: 17053471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and management of renovascular hypertension and ischemic nephropathy.
    Yerram P; Karuparthi PR; Chaudhary K
    Minerva Urol Nefrol; 2012 Mar; 64(1):63-72. PubMed ID: 22402318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus does not preclude stabilization or improvement of renal function after stent revascularization in patients with kidney insufficiency and renal artery stenosis.
    Silva JA; Potluri S; White CJ; Collins TJ; Jenkins JS; Subramanian R; Ramee SR
    Catheter Cardiovasc Interv; 2007 May; 69(6):902-7. PubMed ID: 17192944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic nephropathy: where are we now?
    Textor SC
    J Am Soc Nephrol; 2004 Aug; 15(8):1974-82. PubMed ID: 15284283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue derived mesenchymal stem cell transplantation in the treatment of ischemia/reperfusion induced acute kidney injury in rats. Application route and therapeutic window1.
    Monteiro BS; Santos BSD; Almeida BL; Hiura E; Fiorio WAB; Valdetaro GP; Gonçalves DV; Silva CS; Champion T; Campagnol D
    Acta Cir Bras; 2018 Nov; 33(11):1016-1026. PubMed ID: 30517328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.